{
  "content": "Ulimoen SR, Enger S, Pripp AH, Abdelnoor M, Arnesen H, Gjesdal Ket al. . Calcium channel blockers improve exercise capacity and reduce N-terminal pro-B-type natriuretic peptide levels compared with beta-blockers in patients with permanent atrial fibrillation. Eur Heart J 2014;35:517–24. - PubMed\n\nKotecha D, Bunting KV, Gill SK, Mehta S, Stanbury M, Jones JCet al. . Effect of digoxin vs bisoprolol for heart rate control in atrial fibrillation on patient-reported quality of life: the RATE-AF randomized clinical trial. JAMA 2020;324:2497–508. - PMC - PubMed\n\nShow all 15 references \nMeSH terms\n\nAdrenergic beta-Antagonists / adverse effects \n\nActions \n   Search in PubMed\n   Search in MeSH\n   Add to Search\n\nAtrial Fibrillation / complications",
  "source": "https://pubmed.ncbi.nlm.nih.gov/36748952/",
  "chunk_id": "a651be18-2528-4930-a2ed-fdd261690fde",
  "similarity_score": 0.21330726146697998,
  "query": "beta-blockers safety profile atrial fibrillation heart failure contraindications bradycardia hypotension",
  "rank": 13,
  "title": "Beta-blockers in atrial fibrillation-trying to make sense of unsettling results",
  "authors": "Markus Meyer, Daniel Lustgarten",
  "year": "2023",
  "journal": "Europace",
  "reference": "Meyer, M., & Lustgarten, D. (2023). Beta-blockers in atrial fibrillation-trying to make sense of unsettling results. Europace, 25(2), 260-262. https://doi.org/10.1093/europace/euad010",
  "doi": "10.1093/europace/euad010",
  "chunk_index": 18,
  "total_chunks": 22,
  "retrieved_at": "2025-07-24T21:57:55.188522"
}